Orphazyme recruits new CEO
Just over two months after Orphazyme bid former CEO Kim Stratton farewell, the firm has found her replacement at US biotech firm Amgen.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Going forward, former Senior Vice President, General Manager of Amgen's US oncology business Christophe Bourdon will take the steering wheel at Orphazyme.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Flourishing trade activity in life science industry
For subscribers
.jpg&w=384&q=75)
